YMR130W Antibody

What is YMR130W and what cellular functions does it perform?

YMR130W (UniProt accession: Q04223) is a protein found in Saccharomyces cerevisiae strain ATCC 204508/S288c, commonly known as Baker's yeast . While a full characterization of its function requires further research, current studies suggest it plays roles in cellular metabolism and stress response pathways. When designing experiments to study its function, researchers should consider both loss-of-function approaches (gene knockout, RNA interference) and gain-of-function methodologies (overexpression systems). Antibodies against YMR130W are valuable tools for detecting the protein's expression, localization, and interaction partners within yeast cells.

What applications are validated for YMR130W Antibody?

The YMR130W antibody has been validated for multiple experimental applications, with ELISA and Western Blotting (WB) being the primary validated methods . These techniques can be employed to:

• Detect and quantify YMR130W expression under different experimental conditions

• Verify protein purification processes

• Study post-translational modifications

• Examine protein-protein interactions

When using this antibody for Western Blotting, researchers should optimize blocking conditions (typically 5% non-fat dry milk or BSA in TBST) and antibody dilutions to minimize background signal while maximizing specific binding.

What are the optimal storage and handling conditions for YMR130W Antibody?

For maximum antibody stability and performance, YMR130W antibody should be stored at either -20°C or -80°C upon receipt . Repeated freeze-thaw cycles must be avoided as they can lead to antibody denaturation, aggregation, and loss of binding activity. Consider the following practical laboratory approaches:

• Aliquot the antibody into single-use volumes upon receipt

• Store aliquots in sterile, nuclease-free microcentrifuge tubes

• When handling, always keep the antibody on ice

• Return unused antibody to -20°C or -80°C immediately after use

• Track the number of freeze-thaw cycles for each aliquot

The antibody is supplied in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4 .

How should researchers validate YMR130W Antibody specificity?

Before proceeding with experiments, proper validation of antibody specificity is essential to ensure reliable results. Methodological approaches include:

• Positive and negative controls: Use wild-type yeast expressing YMR130W as a positive control and YMR130W knockout strains as negative controls

• Blocking peptide competition: Pre-incubate the antibody with excess immunizing peptide to confirm signal specificity

• Cross-reactivity testing: Test against closely related yeast species to assess potential cross-reactivity

• Multiple detection methods: Confirm results using orthogonal techniques like immunofluorescence or mass spectrometry

Documenting these validation steps is crucial for publication and reproducibility purposes.

What are the optimal conditions for Western Blotting with YMR130W Antibody?

Optimizing Western Blot conditions for YMR130W antibody requires systematic testing of several parameters. The following table summarizes recommended starting conditions and optimization strategies:

Researchers should document all optimization steps and include both positive and negative controls in each experiment.

How can YMR130W Antibody be employed in immunoprecipitation studies?

Immunoprecipitation (IP) with YMR130W antibody can reveal protein-protein interactions and post-translational modifications. While not explicitly listed in the validated applications , many polyclonal antibodies perform well in IP experiments. A methodological approach includes:

• Cell lysis optimization: Test different lysis buffers to maintain protein complexes while ensuring efficient extraction (start with 25mM Tris-HCl pH 7.4, 150mM NaCl, 1% NP-40, 1mM EDTA, and protease/phosphatase inhibitors)

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Antibody binding: Incubate 2-5 μg of YMR130W antibody with 500-1000 μg of protein lysate overnight at 4°C with gentle rotation

• Bead capture: Add protein A sepharose beads (appropriate for rabbit IgG) and incubate 2-4 hours at 4°C

• Washing: Perform stringent washes (at least 4-5) with decreasing salt concentrations

• Elution: Elute bound proteins with SDS sample buffer for Western blot analysis or with gentler methods for functional studies

• Controls: Include IgG control and input samples in each experiment

What strategies address cross-reactivity in complex yeast samples?

Since the YMR130W antibody is raised against recombinant Saccharomyces cerevisiae YMR130W protein , potential cross-reactivity must be addressed, especially in complex samples. Methodological approaches include:

• Pre-absorption: Incubate the antibody with lysates from YMR130W knockout strains to remove antibodies binding to other epitopes

• Epitope mapping: Identify the specific epitopes recognized by the antibody to predict potential cross-reactive proteins

• Dilution optimization: Test a range of antibody dilutions to find the concentration that maximizes specific signal while minimizing background

• Alternative detection systems: Consider using more sensitive detection methods like chemiluminescence amplification or fluorescent secondaries

• Two-dimensional analysis: Combine with 2D gel electrophoresis to better separate potentially cross-reactive proteins

• Mass spectrometry validation: Use immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody

How should controls be designed for YMR130W Antibody experiments?

Robust experimental design requires careful consideration of appropriate controls:

• Positive controls: Wild-type S. cerevisiae expressing YMR130W

• Negative controls: YMR130W knockout strains

• Loading controls: Housekeeping proteins such as actin or GAPDH

• Antibody controls: Secondary-only controls, isotype controls, and pre-immune serum controls

• Treatment controls: Vehicle controls for any treatment conditions

• Peptide competition: Antibody pre-incubated with immunizing peptide

How can YMR130W Antibody be integrated into multi-omics research approaches?

Modern yeast research increasingly employs multi-omics approaches to gain comprehensive insights. YMR130W antibody can be integrated into these workflows through:

• ChIP-seq studies: If YMR130W has DNA-binding properties, chromatin immunoprecipitation followed by sequencing can map genomic binding sites

• Proteomics integration: Use immunoprecipitation followed by mass spectrometry (IP-MS) to identify interaction partners, then correlate with transcriptomic data

• Spatial proteomics: Combine with subcellular fractionation to determine localization patterns under different conditions

• Time-course analyses: Monitor YMR130W expression, modification, and localization changes in response to environmental stresses or growth phases

• Cross-platform validation: Verify protein-level findings (using the antibody) with mRNA-level data from RNA-seq or microarray studies

This integrated approach provides a more complete understanding of YMR130W's function within the cell's complex molecular networks.

What troubleshooting approaches are recommended for inconsistent results?

When facing inconsistent results with YMR130W antibody, a systematic troubleshooting approach should be employed:

• Antibody quality assessment: Check for signs of degradation, precipitates, or contamination; consider ordering a new lot if necessary

• Optimization matrix: Create a systematic matrix varying multiple parameters (antibody concentration, incubation time, temperature, washing stringency)

• Sample preparation evaluation: Ensure consistent sample preparation by standardizing lysis conditions, protein quantification methods, and storage conditions

• Protocol documentation: Maintain detailed records of all experimental variables to identify potential sources of variability

• Biological variability assessment: Determine if inconsistencies reflect actual biological variation by increasing biological replicates

• Alternative detection methods: Validate findings using orthogonal approaches (e.g., fluorescent tags, mass spectrometry) if antibody-based detection remains problematic

How should quantitative data from YMR130W antibody experiments be analyzed?

Quantitative analysis of YMR130W expression or modification requires rigorous data processing:

• Image acquisition standardization: Use linear range capture settings to avoid saturation in Western blot or immunofluorescence imaging

• Normalization strategies: Normalize to appropriate loading controls and consider total protein normalization approaches (e.g., stain-free gels)

• Statistical analysis: Apply appropriate statistical tests based on experimental design and data distribution; consider consulting a biostatistician for complex experiments

• Biological replicates: Include at least three true biological replicates (separate yeast cultures) rather than just technical replicates

• Effect size reporting: Report fold changes with confidence intervals rather than just p-values

• Data visualization: Present data in formats that accurately represent both the magnitude of effects and their statistical significance

What considerations apply when studying YMR130W interactions with other proteins?

When using YMR130W antibody to study protein-protein interactions, several methodological considerations should be addressed:

• Crosslinking optimization: If employing crosslinking, test multiple reagents (DSS, formaldehyde, etc.) and conditions to preserve physiologically relevant interactions

• Detergent selection: Different detergents can disrupt or preserve various types of protein interactions; test a panel (NP-40, Triton X-100, CHAPS, etc.)

• Salt concentration effects: Titrate salt concentrations to minimize non-specific interactions while maintaining specific ones

• Confirmation approaches: Validate interactions using multiple methods (co-IP in both directions, proximity ligation assays, FRET, etc.)

• Functional validation: Test the biological relevance of identified interactions through genetic approaches (double mutants, synthetic lethality)